Search

everythinglearnresearchcommunity

for

Search:↓

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

STEAP3 protein might help treat hair loss, but more testing is needed.

New technologies improve diagnosis and treatment of digestive disorders.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

δ-GABAA receptors affect alcohol consumption based on the estrous cycle and influence movement regardless of the cycle.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Using growth factor injections and minoxidil together can significantly improve hair growth in people with hair loss.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

The role of γδT-cells in causing alopecia areata remains unclear.

Astrotactin proteins are important for brain and skin development and are linked to several neurodevelopmental disorders.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Removing the ATR gene in adult mice causes rapid aging and stem cell loss.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

Botulinum Toxin Type A can increase hair density and improve hair thickness in androgenetic alopecia with minimal side effects.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Alopecia in transgender individuals on hormone therapy can worsen emotional distress and affect self-esteem.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Hair loss treatment caused more hair loss in a man.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

Ultra-high molecular weight poly-γ-glutamic acid may help promote hair growth.

Botulinum toxin is used for neck, shoulder, calf, and ankle slimming, and hair loss treatment, but can cause muscle weakness and atrophy with regular use.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.